ABVC BioPharma, Inc. Debt Conversion, Converted Instrument, Rate
ABVC BioPharma, Inc. (ABVC) had Debt Conversion, Converted Instrument, Rate of 90.00% as of 2024-01-17, per its 10-Q filed 2024-05-17.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionConvertedInstrumentRate · last filed 2024-08-14
- 2024-01-17: Debt Conversion, Converted Instrument, Rate 90.00%.
- 2023-11-17: Debt Conversion, Converted Instrument, Rate 2.00%; Debt Conversion, Converted Instrument, Rate as first filed 90.00%.
| Period end | Debt Conversion, Converted Instrument, Rate | Debt Conversion, Converted Instrument, Rate as first filed |
|---|---|---|
| 2024-01-17 | 90.00% 10-Q · filed 2024-05-17 | |
| 2023-11-17 | 2.00% 10-Q · filed 2024-08-14 | 90.00% 10-K · filed 2024-03-13 |